| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/12/1997 | CA2243994A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production |
| 09/12/1997 | CA2238029A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
| 09/12/1997 | CA2199351A1 Benzothiophenes, formulations containing same, and methods |
| 09/11/1997 | DE19608665A1 Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New Arylglycinamidderivate, processes for their preparation containing these compounds and pharmaceutical compositions |
| 09/11/1997 | DE19608653A1 Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Pyrimido [5,4-d] pyrimidines, medicaments containing these compounds, their use and process for their preparation |
| 09/11/1997 | DE19608588A1 Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Pyrimido [5,4-d] pyrimidines, medicaments containing these compounds, their use and process for their preparation |
| 09/11/1997 | CA2199414A1 Stable carotenoid emulsions suitable for parenteral administration |
| 09/10/1997 | EP0794194A1 A process for the preparation of 2'-deoxy-2'-halocoformycins or stereoisomers thereof |
| 09/10/1997 | EP0794172A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 09/10/1997 | EP0794171A2 Orthosubstituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic material and medicaments containing them |
| 09/10/1997 | EP0793962A1 Medicament containing a carnitine derivative for treating arteriosclerosis obliterans |
| 09/10/1997 | EP0793961A1 Use of droloxifene for the manufacture of a medicament for increasing serum levels of testosterone |
| 09/10/1997 | EP0793722A2 Modified proteinase inhibitors |
| 09/10/1997 | EP0793674A1 Human neutrophil elastase inhibitors |
| 09/10/1997 | EP0793671A1 Phenylsubstituted 4-azasteroid fluoroderivatives |
| 09/10/1997 | EP0793668A1 Derivatives of carbohydrates and compositions containing them |
| 09/10/1997 | EP0793663A1 (thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides |
| 09/10/1997 | EP0793662A1 Aminomethyl aryl compounds; dopamine receptor subtype selective ligands |
| 09/10/1997 | EP0793661A1 Piperazine, piperidine & tetrahydropyridine derivatives useful as 5-ht1 receptor agonists |
| 09/10/1997 | EP0793660A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 09/10/1997 | EP0793658A1 Oxazole derivatives as antagonists of alpha-1c adrenergic receptors |
| 09/10/1997 | EP0793653A1 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| 09/10/1997 | EP0793649A1 18,19-dinor-vitamin d compounds |
| 09/10/1997 | EP0793648A1 18-nor-vitamin d compounds |
| 09/10/1997 | EP0793643A1 Matrix metalloprotease inhibitors |
| 09/10/1997 | EP0793641A1 Metalloproteinase inhibitors |
| 09/10/1997 | EP0793504A1 Chimeric cytokines and uses thereof |
| 09/10/1997 | EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 09/10/1997 | EP0793499A1 Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound |
| 09/10/1997 | EP0793498A1 Bicyclic heterocyclic compounds for the treatment of impotence |
| 09/10/1997 | EP0793495A1 Freeze-dried ondansetron compositions |
| 09/10/1997 | EP0793494A1 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 09/10/1997 | EP0793493A1 Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds |
| 09/10/1997 | EP0793492A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
| 09/10/1997 | EP0793488A1 Increasing fetal hemoglobin levels using carboxylic esters |
| 09/10/1997 | EP0793486A1 cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION |
| 09/10/1997 | EP0793476A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof |
| 09/10/1997 | EP0712403B1 Matrix metalloprotease inhibitors |
| 09/10/1997 | EP0640070B1 Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 09/10/1997 | CN1159196A Inhibitors of interleukin-1'beta' converting enzyme |
| 09/10/1997 | CN1159195A Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-YL)-3-oxo-4-aza-5'alpha'-androst-1-ene-17'beta'-carboxamide |
| 09/10/1997 | CN1159179A Processes for preparation of (E)-2-fluoromethylene-4-(4-fluorophenyl) butylamine and alkali metal salts of diformylamide |
| 09/10/1997 | CN1158856A Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/10/1997 | CN1158855A Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals |
| 09/10/1997 | CN1158850A New thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/10/1997 | CN1158847A New 4-imidazolidinone compound, process for its preparation and pharmaceutical compositions which contain it |
| 09/10/1997 | CN1158725A Use of 8,9-dehydroestrone as antioxidant |
| 09/09/1997 | US5665886 Neurokinin receptor antagonists |
| 09/09/1997 | US5665883 Treatment of pain, inflammation, migraine, emesis |
| 09/09/1997 | US5665870 Method of purifying keratinocyte growth factor (KGF) |
| 09/09/1997 | US5665862 Neurotrophic factor |
| 09/09/1997 | US5665859 Molecules influencing the shedding of the TNF receptor, their preparation and their use |
| 09/09/1997 | US5665777 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 09/09/1997 | US5665772 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 09/09/1997 | US5665768 Heteroaryl cycloalkenyl hydroxyureas |
| 09/09/1997 | US5665758 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
| 09/09/1997 | US5665754 Phosphodiesterase inhibitors, antiinflammatory agents |
| 09/09/1997 | US5665749 For treating inflammation, allergies or cardiovascular diseases in mammals |
| 09/09/1997 | US5665748 Antidiabetic, hypolipidemic agents |
| 09/09/1997 | US5665745 1,2,5-thiadiazole derivatives for treating diseases of central nervous system |
| 09/09/1997 | US5665743 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
| 09/09/1997 | US5665741 1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of neuronal diseases |
| 09/09/1997 | US5665738 Imidazole derivatives and processes for the preparation thereof |
| 09/09/1997 | US5665737 Phosphodiesterase inhibitors |
| 09/09/1997 | US5665733 3-phenylisoquinol-1(2H)-one derivatives their preparation and their therapeutic application |
| 09/09/1997 | US5665732 Indazole derivatives |
| 09/09/1997 | US5665722 For treating and/or prevention of psychotic disorders |
| 09/09/1997 | US5665719 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 09/09/1997 | US5665718 Anxiolytic, anticonvulsant, muscle relaxant, sedative, hypnotic agents |
| 09/09/1997 | US5665716 24-homo vitamin D derivatives, process for their production and pharmaceutical preparations obtained therefrom |
| 09/09/1997 | US5665713 Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| 09/09/1997 | US5665567 Platelet-derived growth factor |
| 09/09/1997 | US5665375 Reducing fat and cholesterol content by administering l-dopa (dihydroxyphenyl alanine) to poultry |
| 09/09/1997 | US5665335 Combinations of vasoactive substances with fatty acids to prevent hair loss |
| 09/09/1997 | US5665329 Heteroatom-bearing ligands and metal complexes thereof |
| 09/09/1997 | CA2136820C Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 09/04/1997 | WO1997032033A1 Compositions and methods of making embryonic stem cells |
| 09/04/1997 | WO1997032029A1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 09/04/1997 | WO1997031923A1 Proton pump inhibitor |
| 09/04/1997 | WO1997031916A1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 09/04/1997 | WO1997031893A1 Process for scavenging thiols |
| 09/04/1997 | WO1997031654A1 Nitric oxide donors capable of reducing toxicity from drugs |
| 09/04/1997 | WO1997031645A1 Porphyrins as urokinase-type plasminogen activator receptor antagonists |
| 09/04/1997 | WO1997031640A1 Combination therapy for osteoporosis |
| 09/04/1997 | WO1997031637A1 Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence |
| 09/04/1997 | WO1997031634A1 At1 receptor antagonist for the stimulation of apoptosis |
| 09/04/1997 | WO1997031625A1 Inhibition of selectin binding |
| 09/04/1997 | CA2248269A1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 09/04/1997 | CA2247901A1 Proton pump inhibitor |
| 09/04/1997 | CA2247899A1 Process for scavenging thiols |
| 09/04/1997 | CA2247502A1 Compositions and methods of making embryonic stem cells |
| 09/04/1997 | CA2247438A1 Porphyrins as urokinase-type plasminogen activator receptor antagonists |
| 09/04/1997 | CA2198980A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/04/1997 | CA2198979A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/03/1997 | EP0792883A1 Novel derivates of boronic acid, process for their preparation and pharmaceutical compositions containing them |
| 09/03/1997 | EP0792878A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism |
| 09/03/1997 | EP0792647A1 Porphyrins as urokinase-type plasminogen activator receptor antagonists |
| 09/03/1997 | EP0792645A1 Combination therapy to treat osteoporosis |
| 09/03/1997 | EP0792643A1 Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage |
| 09/03/1997 | EP0792642A1 Method of treating conditions with estrogen agonists |